Position in VRTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$140,298,407
+$19,039,131 QoQ
Shares Held
282,444
+4.0% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#89
of 1,735 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. VRTX ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,298,407 | 282,444 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $121,259,276 | 271,553 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $118,210,446 | 260,743 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $99,514,156 | 254,096 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $113,235,283 | 254,347 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $183,867,584 | 456,587 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $269,054,826 | 578,513 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $312,266,888 | 666,212 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $277,317,030 | 663,422 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $270,188,794 | 664,034 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $234,118,389 | 673,257 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $216,571,748 | 615,418 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $198,840,677 | 631,100 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $184,081,655 | 637,446 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $183,138,103 | 632,514 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $192,152,037 | 681,898 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $179,726,907 | 688,688 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $145,848,656 | 664,156 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $118,846,002 | 655,196 | Shares | Sole | 2024-12-06 | |
| 2021-06-30 | $123,354,411 | 611,786 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $120,109,112 | 558,933 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||